• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Shaping the Infant Microbiome With Non-digestible Carbohydrates.用不可消化碳水化合物塑造婴儿微生物群。
Front Microbiol. 2019 Feb 25;10:343. doi: 10.3389/fmicb.2019.00343. eCollection 2019.
2
Impact of dietary fibers in infant formulas on gut microbiota and the intestinal immune barrier.婴儿配方食品中膳食纤维对肠道菌群和肠道免疫屏障的影响。
Food Funct. 2020 Nov 18;11(11):9445-9467. doi: 10.1039/d0fo01700k.
3
Structure-function relationship and impact on the gut-immune barrier function of non-digestible carbohydrates and human milk oligosaccharides applicable for infant formula.不可消化碳水化合物和人乳寡糖的结构-功能关系及其对肠道-免疫屏障功能的影响,适用于婴儿配方奶粉。
Crit Rev Food Sci Nutr. 2024;64(23):8325-8345. doi: 10.1080/10408398.2023.2199072. Epub 2023 Apr 10.
4
Non-digestible carbohydrates in infant formula as substitution for human milk oligosaccharide functions: Effects on microbiota and gut maturation.婴儿配方奶粉中的不可消化碳水化合物作为人乳寡糖功能的替代物:对微生物群和肠道成熟的影响。
Crit Rev Food Sci Nutr. 2019;59(9):1486-1497. doi: 10.1080/10408398.2017.1414030. Epub 2018 Jan 15.
5
Modulation of Intestinal Epithelial Glycocalyx Development by Human Milk Oligosaccharides and Non-Digestible Carbohydrates.人乳寡糖和不可消化碳水化合物对肠道上皮糖萼发育的调节作用。
Mol Nutr Food Res. 2019 Sep;63(17):e1900303. doi: 10.1002/mnfr.201900303. Epub 2019 Jun 11.
6
Consumption of non-digestible oligosaccharides elevates colonic alkaline phosphatase activity by up-regulating the expression of IAP-I, with increased mucins and microbial fermentation in rats fed a high-fat diet.食用不可消化的低聚糖通过上调 IAP-I 的表达来提高结肠碱性磷酸酶的活性,在高脂肪饮食喂养的大鼠中,黏蛋白和微生物发酵增加。
Br J Nutr. 2019 Jan;121(2):146-154. doi: 10.1017/S0007114518003082. Epub 2018 Nov 7.
7
Sialylated galacto-oligosaccharides and 2'-fucosyllactose reduce necrotising enterocolitis in neonatal rats.唾液酸化低聚半乳糖和2'-岩藻糖基乳糖可减轻新生大鼠坏死性小肠结肠炎。
Br J Nutr. 2016 Jul;116(2):294-9. doi: 10.1017/S0007114516002038. Epub 2016 May 23.
8
Infant Gut Microbial Metagenome Mining of α-l-Fucosidases with Activity on Fucosylated Human Milk Oligosaccharides and Glycoconjugates.婴儿肠道微生物宏基因组挖掘具有α-L-岩藻糖苷酶活性的 α-L-岩藻糖苷酶,可作用于人乳寡糖和糖缀合物。
Microbiol Spectr. 2022 Aug 31;10(4):e0177522. doi: 10.1128/spectrum.01775-22. Epub 2022 Aug 9.
9
Distinct fermentation of human milk oligosaccharides 3-FL and LNT2 and GOS/inulin by infant gut microbiota and impact on adhesion of WCFS1 to gut epithelial cells.人乳寡糖 3-FL 和 LNT2 以及 GOS/菊粉的不同发酵及对肠道上皮细胞粘附 WCFS1 的影响。
Food Funct. 2021 Dec 13;12(24):12513-12525. doi: 10.1039/d1fo02563e.
10
Galacto- and Fructo-oligosaccharides Utilized for Growth by Cocultures of Bifidobacterial Species Characteristic of the Infant Gut.半乳糖和果寡糖可被婴儿肠道特征双歧杆菌属的混合培养物利用来生长。
Appl Environ Microbiol. 2020 May 19;86(11). doi: 10.1128/AEM.00214-20.

引用本文的文献

1
Microbiota-Modulating Strategies in Neonates Undergoing Surgery for Congenital Gastrointestinal Conditions: A Narrative Review.先天性胃肠道疾病手术新生儿的微生物群调节策略:一项叙述性综述
Nutrients. 2025 Jul 5;17(13):2234. doi: 10.3390/nu17132234.
2
Human milk oligosaccharides: bridging the gap in intestinal microbiota between mothers and infants.人乳寡糖:弥合母婴肠道微生物群之间的差距。
Front Cell Infect Microbiol. 2025 Jan 6;14:1386421. doi: 10.3389/fcimb.2024.1386421. eCollection 2024.
3
A Comprehensive Review on Dietary Polysaccharides as Prebiotics, Synbiotics, and Postbiotics in Infant Formula and Their Influences on Gut Microbiota.关于婴儿配方奶粉中作为益生元、合生元和后生元的膳食多糖及其对肠道微生物群影响的综合综述
Nutrients. 2024 Nov 28;16(23):4122. doi: 10.3390/nu16234122.
4
A Systematic Review of Isotopically Measured Iron Absorption in Infants and Children Under 2 Years.2岁以下婴幼儿同位素测量铁吸收的系统评价
Nutrients. 2024 Nov 8;16(22):3834. doi: 10.3390/nu16223834.
5
Biological effects of combinations of structurally diverse human milk oligosaccharides.结构多样的人乳寡糖组合的生物学效应
Front Pediatr. 2024 Nov 5;12:1439612. doi: 10.3389/fped.2024.1439612. eCollection 2024.
6
Biotics and bacterial function: impact on gut and host health.生物制剂与细菌功能:对肠道和宿主健康的影响。
ISME J. 2024 Jan 8;18(1). doi: 10.1093/ismejo/wrae226.
7
Detailed Analysis of Prebiotic Fructo- and Galacto-Oligosaccharides in the Human Small Intestine.详细分析人小肠中的益生元果寡糖和半乳糖寡糖。
J Agric Food Chem. 2024 Sep 25;72(38):21152-21165. doi: 10.1021/acs.jafc.4c03881. Epub 2024 Sep 16.
8
Pre- to Postbiotics: The Beneficial Roles of Pediatric Dysbiosis Associated with Inflammatory Bowel Diseases.益生元到合生元:与炎症性肠病相关的儿童肠道菌群失调的有益作用
Microorganisms. 2024 Aug 2;12(8):1582. doi: 10.3390/microorganisms12081582.
9
Milk Bioactive Compounds and Gut Microbiota Modulation: The Role of Whey Proteins and Milk Oligosaccharides.牛奶生物活性成分与肠道微生物群调节:乳清蛋白和牛奶寡糖的作用
Foods. 2024 Mar 16;13(6):907. doi: 10.3390/foods13060907.
10
Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases.肠道微生物群-脑轴与固有免疫在炎症和感染性疾病中的作用研究进展。
Front Cell Infect Microbiol. 2023 Oct 4;13:1282431. doi: 10.3389/fcimb.2023.1282431. eCollection 2023.

本文引用的文献

1
Galacto-Oligosaccharides: Production, Properties, Applications, and Significance as Prebiotics.低聚半乳糖:生产、性质、应用及作为益生元的意义
Compr Rev Food Sci Food Saf. 2010 Sep;9(5):438-454. doi: 10.1111/j.1541-4337.2010.00119.x.
2
Interactions of Surface Exopolysaccharides From and Within the Intestinal Environment.肠道环境中及肠道内表面胞外多糖的相互作用
Front Microbiol. 2018 Oct 11;9:2426. doi: 10.3389/fmicb.2018.02426. eCollection 2018.
3
Beneficial Effect of Intestinal Fermentation of Natural Polysaccharides.天然多糖的肠道发酵有益作用。
Nutrients. 2018 Aug 9;10(8):1055. doi: 10.3390/nu10081055.
4
Human milk oligosaccharides and infant gut bifidobacteria: Molecular strategies for their utilization.人乳寡糖与婴儿肠道双歧杆菌:利用它们的分子策略。
Food Microbiol. 2018 Oct;75:37-46. doi: 10.1016/j.fm.2017.09.001. Epub 2017 Sep 4.
5
Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer.肠道微生物代谢产物丁酸对结直肠癌发生发展的影响。
J Cancer. 2018 Jun 15;9(14):2510-2517. doi: 10.7150/jca.25324. eCollection 2018.
6
Production of a human milk oligosaccharide 2'-fucosyllactose by metabolically engineered Saccharomyces cerevisiae.利用代谢工程化酿酒酵母生产人乳寡糖 2'-岩藻糖基乳糖。
Microb Cell Fact. 2018 Jun 27;17(1):101. doi: 10.1186/s12934-018-0947-2.
7
Characterization and Quantification of Oligosaccharides in Human Milk and Infant Formula.人乳和婴儿配方奶粉中寡糖的特性和定量分析。
J Agric Food Chem. 2018 Jul 5;66(26):6851-6859. doi: 10.1021/acs.jafc.8b01515. Epub 2018 Jun 20.
8
Complementary Mechanisms for Degradation of Inulin-Type Fructans and Arabinoxylan Oligosaccharides among Bifidobacterial Strains Suggest Bacterial Cooperation.双歧杆菌菌株间菊粉型果聚糖和阿拉伯木聚糖低聚糖降解的互补机制表明存在细菌间的合作。
Appl Environ Microbiol. 2018 Apr 16;84(9). doi: 10.1128/AEM.02893-17. Print 2018 May 1.
9
Non-digestible carbohydrates in infant formula as substitution for human milk oligosaccharide functions: Effects on microbiota and gut maturation.婴儿配方奶粉中的不可消化碳水化合物作为人乳寡糖功能的替代物:对微生物群和肠道成熟的影响。
Crit Rev Food Sci Nutr. 2019;59(9):1486-1497. doi: 10.1080/10408398.2017.1414030. Epub 2018 Jan 15.
10
Substrate specificity and transfucosylation activity of GH29 α-l-fucosidases for enzymatic production of human milk oligosaccharides.GH29 α-岩藻糖苷酶的底物特异性和转岩藻糖基活性及其在人乳寡糖酶法生产中的应用。
N Biotechnol. 2018 Mar 25;41:34-45. doi: 10.1016/j.nbt.2017.12.002. Epub 2017 Dec 6.

用不可消化碳水化合物塑造婴儿微生物群。

Shaping the Infant Microbiome With Non-digestible Carbohydrates.

作者信息

Verkhnyatskaya Stella, Ferrari Michela, de Vos Paul, Walvoort Marthe T C

机构信息

Stratingh Institute for Chemistry, Faculty of Science and Engineering, University of Groningen, Groningen, Netherlands.

University Medical Center Groningen, Groningen, Netherlands.

出版信息

Front Microbiol. 2019 Feb 25;10:343. doi: 10.3389/fmicb.2019.00343. eCollection 2019.

DOI:10.3389/fmicb.2019.00343
PMID:30858844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6397869/
Abstract

Natural polysaccharides with health benefits are characterized by a large structural diversity and differ in building blocks, linkages, and lengths. They contribute to human health by functioning as anti-adhesives preventing pathogen adhesion, stimulate immune maturation and gut barrier function, and serve as fermentable substrates for gut bacteria. Examples of such beneficial carbohydrates include the human milk oligosaccharides (HMOs). Also, specific non-digestible carbohydrates (NDCs), such as galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS) are being produced with this purpose in mind, and are currently added to infant formula to stimulate the healthy development of the newborn. They mimic some functions of HMO, but not all. Therefore, many research efforts focus on identification and production of novel types of NDCs. In this review, we give an overview of the few NDCs currently available [GOS, FOS, polydextrose (PDX)], and outline the potential of alternative oligosaccharides, such as pectins, (arabino)xylo-oligosaccharides, and microbial exopolysaccharides (EPS). Moreover, state-of-the-art techniques to generate novel types of dietary glycans, including sialylated GOS (Sia-GOS) and galactosylated chitin, are presented as a way to obtain novel prebiotic NDCs that help shaping the infant microbiome.

摘要

具有健康益处的天然多糖具有高度的结构多样性,其组成单元、连接方式和长度各不相同。它们通过充当抗黏附剂来防止病原体黏附,刺激免疫成熟和肠道屏障功能,并作为肠道细菌的可发酵底物,从而对人类健康做出贡献。这类有益碳水化合物的例子包括人乳寡糖(HMOs)。此外,特定的非消化性碳水化合物(NDCs),如低聚半乳糖(GOS)和低聚果糖(FOS),正是出于这个目的而生产的,目前已添加到婴儿配方奶粉中以促进新生儿的健康发育。它们模拟了HMO的一些功能,但并非全部。因此,许多研究工作都集中在新型NDCs的鉴定和生产上。在这篇综述中,我们概述了目前可用的几种NDCs [GOS、FOS、聚葡萄糖(PDX)],并概述了替代寡糖的潜力,如果胶、(阿拉伯)木寡糖和微生物胞外多糖(EPS)。此外,还介绍了生成新型膳食聚糖的先进技术,包括唾液酸化GOS(Sia-GOS)和半乳糖化几丁质,作为获得有助于塑造婴儿微生物群的新型益生元NDCs的一种方法。